Related to Investigators Find Pathway that May Better Explain How Antidiabetics Like Avandia Work

• Specific Adipose Stromal Cell Surface Receptor and Ligand Identified
  
• GABA Therapy Prevents Type 1 Diabetes and Reverses Established Disease in Mouse Models
  
• Scientists Trigger White Fat to Become Brown Fat-Like to Treat Obesty and Type 2 Diabetes
  
• EMA Recommends Cautious Prescribing of Takeda's Actos due to Bladder Cancer Risk
  
• RNA Splicing Factor Implicated in Obesity-Related Lipogenesis
  
• Amylin and Takeda Shelve Phase II-Stage Combination Obesity Candidate
  
• Studies in Narcoleptic Mouse Model Suggest Orexin Represents Target for Obesity Therapy
  
• Studies Suggest Brain Stem Cells Could Represent Autologous Transplant Therapy for Diabetes
  
• Late-Stage Study Results Show Dynavax’ HBV Vaccine Is Better at Protecting Diabetics than Engerix-B
  
• Gene Knockout Prompts Gut Cells to Take Over Insulin Production in Diabetes
  
• Protein in Fat Cells Protects Against Diabetes
  
• Phase I Anti-Obesity Candidate Dropped on Safety Grounds
  
• "Open" Season at GSK
  
• Old Drug Plays New Tricks on Diabetes and Obesity
  
• Sleep Disorders May Increase Risk of Developing Insulin Resistance Independent of Obesity
  
• Obesity Exacerbates ER Stress, Prompting Extra Glucose Production
  
• Published Studies Uphold Health Risk Concerns about GSK’s Type 2 Diabetes Drug
  
• GSK Halts Enrollment for Postmarketing Avandia Trial as FDA Reviews Safety
  
• FDA Significantly Restricts Access to GSK’s Antidiabetic Avandia
  
• Scientists Claim Region of Hypothalamus Could Represent New Target for Obesity and Diabetes